ABSTRACT
Our patient was a 24-year-old gravida 2 para 0 woman. After delivery, placenta percreta was noticed. There was no postpartum hemorrhage, and the patient desired future pregnancies. Although placenta percreta is rare, its sequelae include potentially lethal hemorrhage and loss of reproduction function. Placenta percreta was confirmed histologically and with ultrasonography and magnetic resonance imaging (MRI). Placenta percreta was treated conservatively with methotrexate. On follow-up, MRI showed a small calcified transmural extension of the placenta throughout the uterus in the right fundal area. Color Doppler ultrasonography showed no blood flow in the corresponding area, and maternal serum human chorionic gonadotropin (hCG) was undetectable. Use of MRI is a new method to detect abnormal placentation, and it could be used on follow-up in selective cases with other follow-up modalities. However, it seems likely that conservative management to preserve future fertility remains a secured and reasonable alternative when a patient has no active bleeding.
KEYWORDS
Abnormal placentation - placenta percreta - methotrexate treatment - magnetic resonance imaging - color Doppler ultrasound
REFERENCES
-
1
Nijman R GW, Mantingh A, Aarnoudse J G.
Persistent retained placenta percreta: methotrexate treatment and Doppler flow characteristics.
BJOG.
2002;
109
587-588
-
2
O'Brien J M, Barton J R, Donaldson E S.
The management of placenta percreta: conservative and operative strategies.
Am J Obstet Gynecol.
1996;
175
1632-1638
-
3
Morken N H, Henriksen H.
Placenta percreta-two cases and review of the literature.
Eur J Obstet Gynecol Reprod Biol.
2001;
100
112-115
-
4
Hudon L, Belfort M A, Broome D R.
Diagnosis and management of placenta percreta. A review.
Obstet Gynecol Surv.
1998;
53
509-517
-
5
Maldjian C, Adam R, Pelosi M, Pelosi III M, Rudelli R D, Maldjian J.
MRI appearance of placenta percreta and placenta accreta.
Magn Reson Imaging.
1999;
17
965-971
Nonna HeiskanenM.D.
PO Box 1777
70211 Kuopio, Finland
